In 2018, medtech companies had a great deal of cash on hand they were eager to spend that capital on acquisitions. Boston Scientific nearly made a move to acquire a company month. But is that the same story in 2019? Do medtech companies have the same hunger as they did in 2018? The answer is no according to Mike Matson, an analyst with Needham & Co. In a research note, Matson wrote when compared to 2018, both the "number of M&A deals and the dollar volume of deals appear likely to decline in 2019."